Global Digital Diagnostics

Digital Diagnostics Comprehensive Study by Type (Human Pathology, Veterinary Pathology), Application (Teleconsultation, Disease Diagnosis, Training & Education, Drug Discovery & Development, Academic Research, Cancer Cell Detection, Others), Product (Software, Device (Scanners, Slide Management System), Storage System), End User (Pharmaceutical & Biotechnology Companies, Hospital and Reference Laboratories, Academic & Research Institutes) Players and Region - Global Market Outlook to 2032

Digital Diagnostics Market by XX Submarkets | Forecast Years 2024-2032 | CAGR: 12.3%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
The global Digital Diagnostics market is expected to witness high demand in the forecasted period due to the rising prevalence of cancer. Digital diagnostics deals with a common tool in which a person can easily collaborate across the entire application lifecycle by allowing quick isolation and resolution of issues. This new technology supports progress in the medical care system by contributing to the precision and correctness of the diagnostics output.

AttributesDetails
Study Period2018-2032
Base Year2023
High Growth MarketAsia Pacific
UnitValue (USD Million)
Key Companies ProfiledLeica Biosystems (Germany), Ventana Medical Systems (United States), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), Philips (Netherlands), Medtronic, Inc. (Ireland), Neurovigil, Inc. (United States), Oxitone Medical Ltd. (Isreal), Cerora (United States), CellScope (United States) and MidMark Corp. (United States)


According to AMA, the market for Digital Diagnostics is expected to register a CAGR of 12.3% during the forecast period to 2032. This growth is primarily driven by The Growing Adoption of Digital Pathology to Enhance Lab Efficiency, The Upsurging Governments Support for Digital Diagnostics and Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems.

Globally, a noticeable market trend is evident The Increasing Demand from Drug Development and Companion Diagnostics The Health Care Facilities sector in the North America region has been increasing at a sustainable rate, and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Leica Biosystems (Germany), Ventana Medical Systems (United States), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), Philips (Netherlands), Medtronic, Inc. (Ireland), Neurovigil, Inc. (United States), Oxitone Medical Ltd. (Isreal), Cerora (United States), CellScope (United States) and MidMark Corp. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years. The global market is highly competitive and consists of a limited number of providers who compete with each other. The intense competition, changing consumer spending patterns, demographic trends, and frequent changes in consumer preferences pose significant opportunities for market growth.

Key Developments in the Market:
On 29th August 2019, Hamamatsu Photonics introduces a new micro PMT encapsulated in a plastic package ideal for downsizing medical diagnostic devices and environmental analyzers. This new micro PMT goes on sale on October 1, 2019.
In September 2023, BT has launched new AI and digital services in diagnostics to support the NHS in tackling wait times and speeding up diagnosis for patients. At the same time it is building on its ability to become a digital aggregator for an overstretched health service faced with a flood of new AI tools.

Influencing Trend:
The Increasing Demand from Drug Development and Companion Diagnostics, Ease of Consultation Enabled By Digital Pathology and Introduction of Affordable Scanners for Private Pathology Practices

Market Growth Drivers:
The Growing Adoption of Digital Pathology to Enhance Lab Efficiency, The Upsurging Governments Support for Digital Diagnostics and Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems

Challenges:
Lack of Standard Guidelines

Restraints:
The Growing Concern Related to High Cost of Digital Pathology

Opportunities:
The ongoing technological advancements in digital pathology systems are projected to contribute to significant market growth. There are various advancements are responsible for market growth including digital imaging, robotic light microscopy, computerization, and multiple fiber optic communications. Whole slide imaging is a popular technology that has various benefits over traditional light microscopes, which is projected to provide lucrative opportunities to the global market.

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints in Digital Diagnostics Market
- Analysis about New Entrants in Digital Diagnostics Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis
- An Unbiased Perspective towards Market Performance & Indicators

Against this Challenging Backdrop, Digital Diagnostics Study Sheds Light on
— The Digital Diagnostics Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Digital Diagnostics industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Digital Diagnostics industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Human Pathology
  • Veterinary Pathology
By Application
  • Teleconsultation
  • Disease Diagnosis
  • Training & Education
  • Drug Discovery & Development
  • Academic Research
  • Cancer Cell Detection
  • Others
By Product
  • Software
  • Device [Scanners, Slide Management System]
  • Storage System

By End User
  • Pharmaceutical & Biotechnology Companies
  • Hospital and Reference Laboratories
  • Academic & Research Institutes

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. The Growing Adoption of Digital Pathology to Enhance Lab Efficiency
      • 3.2.2. The Upsurging Governments Support for Digital Diagnostics
      • 3.2.3. Integration of Laboratory Information Systems (LIS) and Digital Pathology Systems
    • 3.3. Market Challenges
      • 3.3.1. Lack of Standard Guidelines
    • 3.4. Market Trends
      • 3.4.1. The Increasing Demand from Drug Development and Companion Diagnostics
      • 3.4.2. Ease of Consultation Enabled By Digital Pathology
      • 3.4.3. Introduction of Affordable Scanners for Private Pathology Practices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Digital Diagnostics, by Type, Application, Product, End User and Region (value and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Digital Diagnostics (Value)
      • 5.2.1. Global Digital Diagnostics by: Type (Value)
        • 5.2.1.1. Human Pathology
        • 5.2.1.2. Veterinary Pathology
      • 5.2.2. Global Digital Diagnostics by: Application (Value)
        • 5.2.2.1. Teleconsultation
        • 5.2.2.2. Disease Diagnosis
        • 5.2.2.3. Training & Education
        • 5.2.2.4. Drug Discovery & Development
        • 5.2.2.5. Academic Research
        • 5.2.2.6. Cancer Cell Detection
        • 5.2.2.7. Others
      • 5.2.3. Global Digital Diagnostics by: Product (Value)
        • 5.2.3.1. Software
        • 5.2.3.2. Device [Scanners, Slide Management System]
        • 5.2.3.3. Storage System
      • 5.2.4. Global Digital Diagnostics by: End User (Value)
        • 5.2.4.1. Pharmaceutical & Biotechnology Companies
        • 5.2.4.2. Hospital and Reference Laboratories
        • 5.2.4.3. Academic & Research Institutes
      • 5.2.5. Global Digital Diagnostics Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Digital Diagnostics (Price)
      • 5.3.1. Global Digital Diagnostics by: Type (Price)
  • 6. Digital Diagnostics: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Leica Biosystems (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Ventana Medical Systems (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Hamamatsu Photonics (Japan)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. 3DHISTECH (Hungary)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Philips (Netherlands)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Medtronic, Inc. (Ireland)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Neurovigil, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Oxitone Medical Ltd. (Isreal)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Cerora (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. CellScope (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. MidMark Corp. (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Digital Diagnostics Sale, by Type, Application, Product, End User and Region (value and price ) (2027-2032)
    • 7.1. Introduction
    • 7.2. Global Digital Diagnostics (Value)
      • 7.2.1. Global Digital Diagnostics by: Type (Value)
        • 7.2.1.1. Human Pathology
        • 7.2.1.2. Veterinary Pathology
      • 7.2.2. Global Digital Diagnostics by: Application (Value)
        • 7.2.2.1. Teleconsultation
        • 7.2.2.2. Disease Diagnosis
        • 7.2.2.3. Training & Education
        • 7.2.2.4. Drug Discovery & Development
        • 7.2.2.5. Academic Research
        • 7.2.2.6. Cancer Cell Detection
        • 7.2.2.7. Others
      • 7.2.3. Global Digital Diagnostics by: Product (Value)
        • 7.2.3.1. Software
        • 7.2.3.2. Device [Scanners, Slide Management System]
        • 7.2.3.3. Storage System
      • 7.2.4. Global Digital Diagnostics by: End User (Value)
        • 7.2.4.1. Pharmaceutical & Biotechnology Companies
        • 7.2.4.2. Hospital and Reference Laboratories
        • 7.2.4.3. Academic & Research Institutes
      • 7.2.5. Global Digital Diagnostics Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Digital Diagnostics (Price)
      • 7.3.1. Global Digital Diagnostics by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Digital Diagnostics: by Type(USD Million)
  • Table 2. Digital Diagnostics Human Pathology , by Region USD Million (2018-2023)
  • Table 3. Digital Diagnostics Veterinary Pathology , by Region USD Million (2018-2023)
  • Table 4. Digital Diagnostics: by Application(USD Million)
  • Table 5. Digital Diagnostics Teleconsultation , by Region USD Million (2018-2023)
  • Table 6. Digital Diagnostics Disease Diagnosis , by Region USD Million (2018-2023)
  • Table 7. Digital Diagnostics Training & Education , by Region USD Million (2018-2023)
  • Table 8. Digital Diagnostics Drug Discovery & Development , by Region USD Million (2018-2023)
  • Table 9. Digital Diagnostics Academic Research , by Region USD Million (2018-2023)
  • Table 10. Digital Diagnostics Cancer Cell Detection , by Region USD Million (2018-2023)
  • Table 11. Digital Diagnostics Others , by Region USD Million (2018-2023)
  • Table 12. Digital Diagnostics: by Product(USD Million)
  • Table 13. Digital Diagnostics Software , by Region USD Million (2018-2023)
  • Table 14. Digital Diagnostics Device [Scanners, Slide Management System] , by Region USD Million (2018-2023)
  • Table 15. Digital Diagnostics Storage System , by Region USD Million (2018-2023)
  • Table 16. Digital Diagnostics: by End User(USD Million)
  • Table 17. Digital Diagnostics Pharmaceutical & Biotechnology Companies , by Region USD Million (2018-2023)
  • Table 18. Digital Diagnostics Hospital and Reference Laboratories , by Region USD Million (2018-2023)
  • Table 19. Digital Diagnostics Academic & Research Institutes , by Region USD Million (2018-2023)
  • Table 20. South America Digital Diagnostics, by Country USD Million (2018-2023)
  • Table 21. South America Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 22. South America Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 23. South America Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 24. South America Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 25. Brazil Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 26. Brazil Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 27. Brazil Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 28. Brazil Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 29. Argentina Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 30. Argentina Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 31. Argentina Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 32. Argentina Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 33. Rest of South America Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 34. Rest of South America Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 35. Rest of South America Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 36. Rest of South America Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 37. Asia Pacific Digital Diagnostics, by Country USD Million (2018-2023)
  • Table 38. Asia Pacific Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 39. Asia Pacific Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 40. Asia Pacific Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 41. Asia Pacific Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 42. China Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 43. China Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 44. China Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 45. China Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 46. Japan Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 47. Japan Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 48. Japan Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 49. Japan Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 50. India Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 51. India Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 52. India Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 53. India Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 54. South Korea Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 55. South Korea Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 56. South Korea Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 57. South Korea Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 58. Taiwan Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 59. Taiwan Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 60. Taiwan Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 61. Taiwan Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 62. Australia Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 63. Australia Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 64. Australia Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 65. Australia Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 66. Rest of Asia-Pacific Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 67. Rest of Asia-Pacific Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 68. Rest of Asia-Pacific Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 69. Rest of Asia-Pacific Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 70. Europe Digital Diagnostics, by Country USD Million (2018-2023)
  • Table 71. Europe Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 72. Europe Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 73. Europe Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 74. Europe Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 75. Germany Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 76. Germany Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 77. Germany Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 78. Germany Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 79. France Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 80. France Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 81. France Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 82. France Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 83. Italy Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 84. Italy Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 85. Italy Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 86. Italy Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 87. United Kingdom Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 88. United Kingdom Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 89. United Kingdom Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 90. United Kingdom Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 91. Netherlands Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 92. Netherlands Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 93. Netherlands Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 94. Netherlands Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 95. Rest of Europe Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 96. Rest of Europe Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 97. Rest of Europe Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 98. Rest of Europe Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 99. MEA Digital Diagnostics, by Country USD Million (2018-2023)
  • Table 100. MEA Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 101. MEA Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 102. MEA Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 103. MEA Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 104. Middle East Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 105. Middle East Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 106. Middle East Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 107. Middle East Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 108. Africa Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 109. Africa Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 110. Africa Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 111. Africa Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 112. North America Digital Diagnostics, by Country USD Million (2018-2023)
  • Table 113. North America Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 114. North America Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 115. North America Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 116. North America Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 117. United States Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 118. United States Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 119. United States Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 120. United States Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 121. Canada Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 122. Canada Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 123. Canada Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 124. Canada Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 125. Mexico Digital Diagnostics, by Type USD Million (2018-2023)
  • Table 126. Mexico Digital Diagnostics, by Application USD Million (2018-2023)
  • Table 127. Mexico Digital Diagnostics, by Product USD Million (2018-2023)
  • Table 128. Mexico Digital Diagnostics, by End User USD Million (2018-2023)
  • Table 129. Digital Diagnostics: by Type(USD/Units)
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Digital Diagnostics: by Type(USD Million)
  • Table 142. Digital Diagnostics Human Pathology , by Region USD Million (2027-2032)
  • Table 143. Digital Diagnostics Veterinary Pathology , by Region USD Million (2027-2032)
  • Table 144. Digital Diagnostics: by Application(USD Million)
  • Table 145. Digital Diagnostics Teleconsultation , by Region USD Million (2027-2032)
  • Table 146. Digital Diagnostics Disease Diagnosis , by Region USD Million (2027-2032)
  • Table 147. Digital Diagnostics Training & Education , by Region USD Million (2027-2032)
  • Table 148. Digital Diagnostics Drug Discovery & Development , by Region USD Million (2027-2032)
  • Table 149. Digital Diagnostics Academic Research , by Region USD Million (2027-2032)
  • Table 150. Digital Diagnostics Cancer Cell Detection , by Region USD Million (2027-2032)
  • Table 151. Digital Diagnostics Others , by Region USD Million (2027-2032)
  • Table 152. Digital Diagnostics: by Product(USD Million)
  • Table 153. Digital Diagnostics Software , by Region USD Million (2027-2032)
  • Table 154. Digital Diagnostics Device [Scanners, Slide Management System] , by Region USD Million (2027-2032)
  • Table 155. Digital Diagnostics Storage System , by Region USD Million (2027-2032)
  • Table 156. Digital Diagnostics: by End User(USD Million)
  • Table 157. Digital Diagnostics Pharmaceutical & Biotechnology Companies , by Region USD Million (2027-2032)
  • Table 158. Digital Diagnostics Hospital and Reference Laboratories , by Region USD Million (2027-2032)
  • Table 159. Digital Diagnostics Academic & Research Institutes , by Region USD Million (2027-2032)
  • Table 160. South America Digital Diagnostics, by Country USD Million (2027-2032)
  • Table 161. South America Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 162. South America Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 163. South America Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 164. South America Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 165. Brazil Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 166. Brazil Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 167. Brazil Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 168. Brazil Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 169. Argentina Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 170. Argentina Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 171. Argentina Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 172. Argentina Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 173. Rest of South America Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 174. Rest of South America Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 175. Rest of South America Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 176. Rest of South America Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 177. Asia Pacific Digital Diagnostics, by Country USD Million (2027-2032)
  • Table 178. Asia Pacific Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 179. Asia Pacific Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 180. Asia Pacific Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 181. Asia Pacific Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 182. China Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 183. China Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 184. China Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 185. China Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 186. Japan Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 187. Japan Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 188. Japan Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 189. Japan Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 190. India Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 191. India Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 192. India Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 193. India Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 194. South Korea Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 195. South Korea Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 196. South Korea Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 197. South Korea Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 198. Taiwan Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 199. Taiwan Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 200. Taiwan Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 201. Taiwan Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 202. Australia Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 203. Australia Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 204. Australia Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 205. Australia Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 206. Rest of Asia-Pacific Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 207. Rest of Asia-Pacific Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 208. Rest of Asia-Pacific Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 209. Rest of Asia-Pacific Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 210. Europe Digital Diagnostics, by Country USD Million (2027-2032)
  • Table 211. Europe Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 212. Europe Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 213. Europe Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 214. Europe Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 215. Germany Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 216. Germany Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 217. Germany Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 218. Germany Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 219. France Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 220. France Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 221. France Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 222. France Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 223. Italy Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 224. Italy Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 225. Italy Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 226. Italy Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 227. United Kingdom Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 228. United Kingdom Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 229. United Kingdom Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 230. United Kingdom Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 231. Netherlands Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 232. Netherlands Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 233. Netherlands Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 234. Netherlands Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 235. Rest of Europe Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 236. Rest of Europe Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 237. Rest of Europe Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 238. Rest of Europe Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 239. MEA Digital Diagnostics, by Country USD Million (2027-2032)
  • Table 240. MEA Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 241. MEA Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 242. MEA Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 243. MEA Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 244. Middle East Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 245. Middle East Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 246. Middle East Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 247. Middle East Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 248. Africa Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 249. Africa Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 250. Africa Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 251. Africa Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 252. North America Digital Diagnostics, by Country USD Million (2027-2032)
  • Table 253. North America Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 254. North America Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 255. North America Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 256. North America Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 257. United States Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 258. United States Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 259. United States Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 260. United States Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 261. Canada Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 262. Canada Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 263. Canada Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 264. Canada Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 265. Mexico Digital Diagnostics, by Type USD Million (2027-2032)
  • Table 266. Mexico Digital Diagnostics, by Application USD Million (2027-2032)
  • Table 267. Mexico Digital Diagnostics, by Product USD Million (2027-2032)
  • Table 268. Mexico Digital Diagnostics, by End User USD Million (2027-2032)
  • Table 269. Digital Diagnostics: by Type(USD/Units)
  • Table 270. Research Programs/Design for This Report
  • Table 271. Key Data Information from Secondary Sources
  • Table 272. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Digital Diagnostics: by Type USD Million (2018-2023)
  • Figure 5. Global Digital Diagnostics: by Application USD Million (2018-2023)
  • Figure 6. Global Digital Diagnostics: by Product USD Million (2018-2023)
  • Figure 7. Global Digital Diagnostics: by End User USD Million (2018-2023)
  • Figure 8. South America Digital Diagnostics Share (%), by Country
  • Figure 9. Asia Pacific Digital Diagnostics Share (%), by Country
  • Figure 10. Europe Digital Diagnostics Share (%), by Country
  • Figure 11. MEA Digital Diagnostics Share (%), by Country
  • Figure 12. North America Digital Diagnostics Share (%), by Country
  • Figure 13. Global Digital Diagnostics: by Type USD/Units (2018-2023)
  • Figure 14. Global Digital Diagnostics share by Players 2023 (%)
  • Figure 15. Global Digital Diagnostics share by Players (Top 3) 2023(%)
  • Figure 16. Global Digital Diagnostics share by Players (Top 5) 2023(%)
  • Figure 17. BCG Matrix for key Companies
  • Figure 18. Leica Biosystems (Germany) Revenue, Net Income and Gross profit
  • Figure 19. Leica Biosystems (Germany) Revenue: by Geography 2023
  • Figure 20. Ventana Medical Systems (United States) Revenue, Net Income and Gross profit
  • Figure 21. Ventana Medical Systems (United States) Revenue: by Geography 2023
  • Figure 22. Hamamatsu Photonics (Japan) Revenue, Net Income and Gross profit
  • Figure 23. Hamamatsu Photonics (Japan) Revenue: by Geography 2023
  • Figure 24. 3DHISTECH (Hungary) Revenue, Net Income and Gross profit
  • Figure 25. 3DHISTECH (Hungary) Revenue: by Geography 2023
  • Figure 26. Philips (Netherlands) Revenue, Net Income and Gross profit
  • Figure 27. Philips (Netherlands) Revenue: by Geography 2023
  • Figure 28. Medtronic, Inc. (Ireland) Revenue, Net Income and Gross profit
  • Figure 29. Medtronic, Inc. (Ireland) Revenue: by Geography 2023
  • Figure 30. Neurovigil, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Neurovigil, Inc. (United States) Revenue: by Geography 2023
  • Figure 32. Oxitone Medical Ltd. (Isreal) Revenue, Net Income and Gross profit
  • Figure 33. Oxitone Medical Ltd. (Isreal) Revenue: by Geography 2023
  • Figure 34. Cerora (United States) Revenue, Net Income and Gross profit
  • Figure 35. Cerora (United States) Revenue: by Geography 2023
  • Figure 36. CellScope (United States) Revenue, Net Income and Gross profit
  • Figure 37. CellScope (United States) Revenue: by Geography 2023
  • Figure 38. MidMark Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 39. MidMark Corp. (United States) Revenue: by Geography 2023
  • Figure 40. Global Digital Diagnostics: by Type USD Million (2027-2032)
  • Figure 41. Global Digital Diagnostics: by Application USD Million (2027-2032)
  • Figure 42. Global Digital Diagnostics: by Product USD Million (2027-2032)
  • Figure 43. Global Digital Diagnostics: by End User USD Million (2027-2032)
  • Figure 44. South America Digital Diagnostics Share (%), by Country
  • Figure 45. Asia Pacific Digital Diagnostics Share (%), by Country
  • Figure 46. Europe Digital Diagnostics Share (%), by Country
  • Figure 47. MEA Digital Diagnostics Share (%), by Country
  • Figure 48. North America Digital Diagnostics Share (%), by Country
  • Figure 49. Global Digital Diagnostics: by Type USD/Units (2027-2032)
List of companies from research coverage that are profiled in the study
  • Leica Biosystems (Germany)
  • Ventana Medical Systems (United States)
  • Hamamatsu Photonics (Japan)
  • 3DHISTECH (Hungary)
  • Philips (Netherlands)
  • Medtronic, Inc. (Ireland)
  • Neurovigil, Inc. (United States)
  • Oxitone Medical Ltd. (Isreal)
  • Cerora (United States)
  • CellScope (United States)
  • MidMark Corp. (United States)
Additional players considered in the study are as follows:
MC10, Inc. (United States) , Qardio, Inc. (United States) , Vital Connect (United States) , Fever Smart (United States) , UE LifeSciences, Inc. (United States) , Biomeme (United States)
Select User Access Type

Key Highlights of Report


Jul 2024 247 Pages 67 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Digital Diagnostics Quantitative research analysis
Global Digital Diagnostics Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Top performing companies in the Global Digital Diagnostics market are Leica Biosystems (Germany), Ventana Medical Systems (United States), Hamamatsu Photonics (Japan), 3DHISTECH (Hungary), Philips (Netherlands), Medtronic, Inc. (Ireland), Neurovigil, Inc. (United States), Oxitone Medical Ltd. (Isreal), Cerora (United States), CellScope (United States) and MidMark Corp. (United States), to name a few.
North America is dominating the Digital Diagnostics Market.
"Lack of Standard Guidelines" is seen as one of the major challenges by many Industry Players of Digital Diagnostics Market
The Digital Diagnostics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get complete companies available in our research coverage.
The Digital Diagnostics market is expected to see a steady growth rate during projected year 2023 to 2032.

Know More About Global Digital Diagnostics Report?

Have a Query? Click Here

Other Related Reports

Limb Salvage Systems Comprehensive Study by Type (Allo-metal Prostheses, Metal Prosthesis, Allograft), Application (Hospitals, Orthopedic and Prosthetic Clinics, Others) Players and Region - Global M...
$ 3500
Sepsis Diagnostics Comprehensive Study by Type (Microbiology, Molecular Diagnostics, Immunoassays, Flow Cytometry, Microfluidics, Biomarkers), Products (Blood Culture Media, Assays & Reagents, Instru...
$ 3750
Small Molecule Targeted Cancer Therapy Comprehensive Study by Type (Monoclonal Antibodies, Small Molecules, Small Molecule Drug Conjugates), Application (Lymphoma, Melanoma, Multiple Myeloma, Breast ...
$ 3750
Artificial Vital Organs Comprehensive Study by Type (Artificial Liver, Artificial Heart, Artificial Pancreas, Artificial Kidney, Artificial Lungs), Application (Hospitals, Clinics, Research Centers, ...
$ 3500
Digital Genome Comprehensive Study by Application (Microbiology {Biological, Clinical, Industrial}, Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Develop...
$ 3750
Microalbumin Test Comprehensive Study by Type (Random Urine test, 24 hour urine test, Timed urine test), Application (Hospitals, Clinics, Diagnostics Laboratories, Others), End Users (Hospitals, Clin...
$ 3650